# Maze Therapeutics Inc. (MAZE) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $26.21, market value $1.5 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Maze Therapeutics Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 8.7×**. Each dollar of revenue is priced at 8.7×.
- **Price / book: 3.2×**. The shares trade at 3.2× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -7.3%** (5-yr avg -6.3%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Operating margin: 34.4%**. 34.4% of revenue is left after running the business, an exceptional level.
- **Return on equity: -36.9%**. Return on equity is negative because earnings are negative.
- **Return on assets: 13.2%**. Each dollar of assets produces 13.2% of profit.

## Growth
- **EPS growth (1 yr): -344.0%**. Earnings per share fell 344.0%.

## Financial health
- **Current ratio: 15.50** (quick 15.50). Current assets cover the next year's liabilities 15.50 times.
- **Piotroski F-score: 2/9**. 2 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Maze Therapeutics Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (11 analysts). 11 analysts cover Maze Therapeutics Inc.; the consensus is strong_buy, with an average price target of $62.55 (+139% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 74.3%** (YTD -36.7%, 3-mo 8.0%). The shares are up 74.3% over twelve months including dividends.
- **From 52-week high: -51.1%** (77.7% above the low). Trading 51% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 40**. An RSI of 40 is neutral.
- **Beta (1 yr): 1.05** (volatility 83%). Beta of 1.05 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=MAZE · Page: https://foliofundamentals.com/stocks/maze

Not investment advice.